BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 15952178)

  • 1. Heparin-binding epidermal growth factor-like growth factor stimulates cell proliferation in cerebral cortical cultures through phosphatidylinositol 3'-kinase and mitogen-activated protein kinase.
    Jin K; Mao XO; Del Rio Guerra G; Jin L; Greenberg DA
    J Neurosci Res; 2005 Aug; 81(4):497-505. PubMed ID: 15952178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.
    El-Assal ON; Besner GE
    Gastroenterology; 2005 Aug; 129(2):609-25. PubMed ID: 16083716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival.
    Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G
    Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J; Adam RM; Santiestevan E; Freeman MR
    Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association.
    Ellerbroek SM; Halbleib JM; Benavidez M; Warmka JK; Wattenberg EV; Stack MS; Hudson LG
    Cancer Res; 2001 Mar; 61(5):1855-61. PubMed ID: 11280738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor stimulation of RPE cell survival: contribution of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
    Defoe DM; Grindstaff RD
    Exp Eye Res; 2004 Jul; 79(1):51-9. PubMed ID: 15183100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
    Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
    Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
    J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease.
    Hollborn M; Iandiev I; Seifert M; Schnurrbusch UE; Wolf S; Wiedemann P; Bringmann A; Kohen L
    Curr Eye Res; 2006 Oct; 31(10):863-74. PubMed ID: 17050278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways.
    Zubilewicz A; Hecquet C; Jeanny J; Soubrane G; Courtois Y; Mascarelli F
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):488-96. PubMed ID: 11157888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
    Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
    Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway.
    Torroglosa A; Murillo-Carretero M; Romero-Grimaldi C; Matarredona ER; Campos-Caro A; Estrada C
    Stem Cells; 2007 Jan; 25(1):88-97. PubMed ID: 16960136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L; Smyth D; Kerr C; Catterall J; Richards CD
    Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
    Hassan S; Dobner PR; Carraway RE
    Regul Pept; 2004 Aug; 120(1-3):155-66. PubMed ID: 15177934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration.
    Zhuang S; Dang Y; Schnellmann RG
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F365-72. PubMed ID: 15213065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
    Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
    Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.